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In this study we provide guidance on the biologically most relevant dose metric for
pulmonary toxicity of biopersistent, spherical nanoparticles (NPs). A retrospective analysis
of nine in vivo studies on particle-induced, acute pulmonary toxicity in animal models
(mouse, rat) was performed encompassing ﬁve different types of nanomaterials (poly-
styrene, titanium dioxide, carbonaceous materials, transition metal oxides (Co, Ni, Zn) and
hydrothermally synthesized α-quartz) with a wide range of primary particle diameters
(9–535 nm) and mass-speciﬁc BET surface areas (6–800 m2/g). The acute inﬂux of poly-
morphonuclear neutrophils (PMNs) into the lungs after intratracheal instillation of NPs
was chosen as a toxicological endpoint for acute lung inﬂammation. The allometrically
scaled toxicological data were investigated with respect to various dose metrics, namely
(primary) particle number, joint length, BET and geometric surface area, volume and mass.
Surface area is identiﬁed as the biologically most relevant dose metric for spherical
NPs explaining about 80% of the observed variability in acute pulmonary toxicity
(R2¼0.77). None of the other dose metrics explains more than 50% of the observed
variability in pulmonary inﬂammation. Moreover, using surface area as the dose metric
allows identiﬁcation of material-based toxicity classes independent of particle size.
Typical materials without intrinsic toxicity – here referred to as low-solubility, low-
toxicity (LSLT) materials – show low surface-speciﬁc toxicity with an EC50 dose of 175 m
2/
g-lung (geometric mean; σg¼2.2), where EC50 represents the dose inducing 50% of the
maximum effect (here 30% PMN). In contrast, transition metal oxides (here Co, Ni, Zn) –
materials known for their intrinsic toxicity – display a 12-fold enhanced surface-speciﬁc
toxicity compared to LSLT particles (EC50¼15 m2/g-lung).
This analysis implies that surface-related modes of action are driving acute pulmonary
toxicity for the types of NPs investigated here. The relevance of other dose metrics such as
number and volume is acknowledged in the context of different modes of action, namely
shape-induced toxicity (ﬁber paradigm) and extremely high particle lung burden (over-
load conditions), respectively. So which dose metric should be monitored by aerosol
scientists involved in health related aerosol exposure measurements? The short answer is
– all of them (except length), but there is a strong preference towards surface area.
& 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).er Ltd. This is an open access article under the CC BY-NC-ND license
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Epidemiological studies have described correlations between the mass concentration of ambient particulate matter (PM)
and increased morbidity and mortality in adults and children (Salvi, 2007; Stone, Johnston, & Clift, 2007). The tremendous
economic success of consumer products containing nanomaterials (e.g. sun screen, tooth paste, tires) has raised concerns
regarding consumer exposure to inhaled nanostructured materials. However, very little epidemiological data are available
for engineered nanomaterials. The few studies performed at industrial sites of nanoparticle (NP) production (mainly carbon
black) did not show conclusive evidence of particle-induced health effects (Boffetta et al., 2004). However, most of these
studies suffer from a lack of accurate exposure data or even personalized lung-deposited dose information (Peters, Ruckerl,
& Cyrys, 2011).
Improved exposure studies are under way, but it is still unclear which of the possible dose metrics is best suited for
predicting the adverse health outcome of NP exposure. While most (ambient) epidemiological studies were based on mass
as the dose metric, there are also a few short-term epidemiological studies indicating that early, transient exacerbations are
associated with the number concentration of ultraﬁne ambient particles rather than the mass of ambient PM (Peters et al.,
2011). In toxicology, mass has been used as the dose metric, since mass is the biologically effective dose metric for soluble
toxins. However, for non-soluble (or poorly-soluble) soot or engineered NPs only the molecules detached from the surface or
located at the surface of the NPs are interacting with the biological ﬂuids and tissue. Hence, surface area is likely to be a
biologically more relevant dose metric for biopersistent nano-/microparticles than mass. This was conﬁrmed by numerous
cell-based in vitro and animal-based in vivo toxicity studies (Oberdörster, Oberdörster, & Oberdörster, 2005; Stoeger,
Schmid, Takenaka, & Schulz, 2007; Stoeger et al., 2009; Waters et al., 2009). However, some toxicological studies have also
suggested particle number or volume as the most relevant dose metric for NPs (Donaldson et al., 2013; Pauluhn, 2011).
State-of-the art aerosol technologies for real-time measurement of all moments of the size distribution (number, length,
surface area, volume/mass) of compact aerosols are available (Kulkarni, Baron, & Willeke, 2011). Moreover, the number, joint
length (Wittmaack, 2002), surface area and volume/mass of loosely agglomerated NPs (“soot-like” agglomerates/aggregates)
can be determined in real-time by multi-instrument approaches (Wang et al., 2010). For non-hygroscopic, compact NPs
(o300 nm) the lung-deposited surface area concentration can be monitored directly in real-time by electrometer based
measurement techniques (Fissan, Neumann, Trampe, Pui, & Shin, 2007). However, for optimized design of future aerosol
exposure measurements related to workplace safety or other health-related issues, it is important to identify the biologically
most effective dose metric.
In this retrospective analysis of selected animal studies on acute pulmonary toxicity of intratracheally instilled NPs we
provide guidance on the biologically most relevant dose metric for acute lung inﬂammation. We investigated the correlation
between acute pulmonary inﬂammation as evidenced by the inﬂux of inﬂammatory cells into the lung and pulmonary
(primary particle) number, joint length, (BET and geometric) surface area, volume and mass as dose metrics. Published data
were compiled from nine different studies conducted by various laboratories using different animal models (mouse, rat).
The data cover some of the most commonly used types of NPs (polystyrene, titanium dioxide, various carbonaceous
materials including aged diesel soot, quartz, and transition metal oxides) covering a wide range of primary particle dia-
meters (9–535 nm) and mass-speciﬁc BET surface areas (6–800 m2/g). Retrospective analysis of this uniﬁed data set pro-
vides insight into the relevance of the various dose metrics for predicting NP-induced pulmonary toxicity.2. Materials and methods
The study presented here is based on animal studies on acute pulmonary toxicity due to intratracheal instillation of NPs
into the lung. More than 60 animal studies on acute pulmonary toxicity published between 2001 and 2009 were screened
and nine of them were selected for matching all of the following criteria:
(1) Use of mouse or rat as animal models
(2) Particles were applied to the lungs via intratracheal instillation
(3) Data on the inﬂux of polymorphonuclear cells (PMNs) into the lung as hallmark of inﬂammation are available for at least
one (acute) time point (between 16 h and 24 h after particle application). The number of PMNs and the total number of
cells on the lung epithelium was determined via differential cell counting of the bronchoalveolar lavage (BAL) ﬂuid.
(4) Non- or poorly-soluble, smooth, nano-sized (o535 nm) primary particles of spherical shape were used. The state of
agglomeration in the applied NP suspension is typically not reported and therefore not considered as criterion here.
(5) Lung-deposited (instilled) mass dose, mass-speciﬁc BET surface area and material density are reported (or available).
(6) Accurate information on the primary particle diameter is provided for conversion of the pulmonary mass dose into
other dose metrics, namely number, (joint) length, geometric surface area.
As mouse and rat are the most frequently used animal models for particle toxicity studies, we included both rat and
mouse data here. NPs were delivered to the lungs via intratracheal instillation, i.e. the anesthetized animals were intra-
tracheally intubated and a deﬁned volume of a NP suspension was squirted directly into the lungs with a syringe via the
trachea. While this route of application is physiologically not realistic (not an aerosol, but a liquid bolus of a NP suspension is
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lungs of animals. To account for the large difference in body weight of mice and rats the applied NP doses were allome-
trically scaled. As we are focusing on pulmonary effects we chose the lung weight as allometric scaling factor. For 7–12
weeks old adult mice lung weights between 0.14 and 0.25 g with an average of about 0.18 g were observed for various
strains (Kida, Fujino, & Thurlbeck, 1989). For rats an average value of 1.3 g was reported for the frequently used Fischer F344
rats (1.1–1.5 g; male, 7–20 weeks old; (Tillery & Lehnert, 1986)). The choice of 1.3 g and 0.18 g of lung weight for rats and
mice, respectively, is also consistent with the widely used allometric dose scaling based on body surface area (Reagan-Shaw,
Nihal, & Ahmad, 2008).
Pulmonary inﬂammation was chosen as the toxicological endpoint, since this represents one of the most sensitive
cellular responses and is also considered one of the key adverse effects induced by particulate air pollution (Donaldson,
Mills, Macnee, Robinson, & Newby, 2005). The most relevant hallmark of acute pulmonary inﬂammation is the inﬂux of
inﬂammatory leukocytes, especially polymorphonuclear neutrophils (PMNs) (Henderson, 2005), into the airspace of the
lungs which can be determined by bronchoalveolar lavage (BAL) of the lung (rinsing the epithelial surface of the lung with
saline solution) and subsequent counting of the number of PMNs in the recovered BAL ﬂuid. A healthy, noninﬂamed lung
contains virtually no PMNs, so that the resident alveolar macrophages will be the only leukocyte population recovered by
BAL. Species-, strain- and handling-speciﬁc differences in the total number of PMNs retrieved from the lungs are accounted
for by normalizing the number of PMNs to the total number of cells in the BAL ﬂuid. As PMN inﬂux into the lung is a time
dependent process with a maximum response typically around 24 h only data obtained between 16 and 24 h after NP
application were included in this study.
The pulmonary particle dose was assumed to be the nominal dose, i.e. it was derived from the concentration and the
nominally applied volume of the NP suspension. This is an approximation, since a certain fraction of the nominal dose will
remain in the instillation tools. In our laboratory ca. 85710% of nominal dose is delivered to the lung (Barapatre et al., 2015).
This systematic (negative) dose bias of about 15% with an uncertainty of about 710% was neglected, since it is expected to
be similar for instillation-studies and it is much smaller than the about 72.2-fold dose variability within a given toxicity
class of particles (see below).
Only materials with low or poor solubility in aqueous media were included, since biopersistent particles were the focus
of the present study. Moreover, for calculation of the various dose metrics, namely number (of primary NPs), joint length,
geometric and BET surface area as well as volume and mass of the applied NPs, only studies providing the following
information were included: diameter of the (spherical) primary NPs (dp), material density, applied total NP mass (M) and
mass-speciﬁc BET surface area (saBET), i.e. the surface area per mass according to the gas adsorption method described by
Brunauer, Emmet, and Teller (1938).
From this information the primary particle number (Np), joint length (Lp) and geometric surface area (SAgeom) of the
applied NPs was calculated according to
Np ¼
M
ρp πd
3
p=6
 ; Lp ¼Npdp and SAgeom ¼Npπd2p ; ð1Þ
respectively, where M and ρp represent the applied NP mass and the material density, respectively. Moreover, the BET
surface area dose SABET was calculated from
SABET ¼ saBETM; ð2Þ
where saBET is the mass-speciﬁc BET surface area (m2/g). The volume dose V is given by
V ¼ M
ρpf
ð3aÞ
where f¼0.74 is the volume ﬁlling fraction of closely packed spheres, which accounts for the void spaces between the
primary particles. The assumption of a close packed structure is justiﬁed by the toxicological mode of action related to
volume as dose metric. As discussed in more detail below for chronic exposures, if the volume of NPs, which is taken up
(phagocytized) by alveolar macrophages, exceeds a limiting (overload) dose, macrophage-mediated clearance of the
nanoparticles from the alveolar region is inhibited and PMN release into the lung is observed (Pauluhn, 2011). It has been
shown that even loosely packed NP agglomerates are strongly compacted inside macrophages justifying the assumption of a
close packed NP structure for estimating the effective volume dose (Takenaka et al., 2012). For interpretation of the volume
data with respect to the so-called overload conditions, it is important to normalize the phagocytized NP volume to the total
volume of the alveolar macrophages in the lung, which is given by Eq. (3b) for rats (Pauluhn, 2011)
Valv;mac ¼ 7 1010μm3=kg  0:3 kg ¼ 2:1 1010μm3: for ratsð Þ ð3bÞ
This equation can be allometrically scaled for mice
Valv;mac ¼ 7 1010μm3=kg  0:3 kg
0:18 g
1:3 g
¼ 2:9 109μm3; for mice ð3cÞ
based on lung and body weight as justiﬁed above (assumed body weight for rat/mouse: 300 g/20 g; lung weight: 1.3 g/
0.18 g).
Table 1
Physico-chemical characteristics of the different types of (agglomerated) nanoparticles (NPs) included in the retrospective study presented here. Particles
were applied directly into the lungs of mice and rats via intratracheal instillation (i.e. as liquid bolus not as aerosol).
Material (nanoparticles) Dose Animal Reference
Type Primary dia-
meter (nm)
Density (g/
cm3)
Mass-speciﬁc
BETa surface area
(m2/g)
Ratio geometric/
BET surface area
Mass dose
per animal
(mg)
Species
Polystyrene 65 1.05 89.3b 1b 0.125, 1 Rat Brown, Wilson, MacNee,
Stone, and Donaldson
(2001)
202 28.3b 1b 0.125, 1
535 10.7b 1b 0.125, 1
Titanium dioxide 20 3.9 50 1.5 0.032, 0.125,
0.5
Rat Oberdörster et al. (2005)
250 6.5 0.95 0.125, 0.5, 2
20 3.9 50 1.5 0.005, 0.025,
0.1
Mouse Oberdörster et al. (2005)
250 6.5 0.95 0.025, 0.1, 0.4
300 3.9 6 0.85 0.275, 1.375 Rat Warheit, Webb, Sayes,
Colvin, and Reed (2006)
20 3.9 50 1.5 0.125 Rat Dick, Brown, Donaldson,
and Stone (2003)
25 50 1.2 1, 6 Rat Hohr et al. (2002)
180 6.5 0.85 1, 6
Hydrophobic 25 50 1.2 1, 6
(methylation) 180 6.5 0.85 1, 6
Carbonaceous materials
Printex 90 14 2 272 0.79 0.184 Rat Lu et al. (2009)
0.79 0.125 Rat Dick et al. (2003)
0.79 0.005, 0.02,
0.05
Mouse Stoeger et al. (2006)
5 Other types of carbo-
naceous materialsc
9, 11, 12, 25, 51 2 800, 441, 268,
108, 43
0.42, 0.62, 0.93,
1.1, 1.4
0.005, 0.02,
0.05
Mouse Stoeger et al. (2006)
Transition metal oxides
Co3O4-nano 20 — 37 — 0.125 Rat Dick et al. (2003)
Ni-nano 20 — 36 — 0.125
ZnO-nano 60 5.6 12.1 1.5 0.25, 1.25 Rat Sayes, Reed, and Warheit
(2007)
ZnO-ﬁne –d 5.6 9.6 — 0.25, 1.25
Silica
Nanoquartze 12, 50 2.65 91, 31 2.1, 1.4 0.275, 1.375 Rat Warheit et al. (2007)
a Surface area characterized by gas adsorption according to the method described by Brunauer et al. (1938).
b The BET surface area was calculated from the geometric diameter.
c In addition to Printex90 (carbon black), spark-discharge generated elemental carbon as well as four other types of combustion-derived soot types
were investigated, namely PrintexG (carbon black), diesel exhaust particles, gas ﬂame soot with low and high organic carbon content.
d Diameter of ca. 1000 nm according to manufacturer's information; however, since the accuracy is uncertain, it was not included in analysis of dose
metrics relying on primary particle diameter for calculation of number, joint length, geometric surface area.
e α-Crystalline silica (SiO2); was synthesized hydrothermally in NaOH, but not mined and milled as most commercially available quartz types (e.g. Min-
U-Sil).
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In this comparative study in vivo animal data from our laboratory (Stoeger et al., 2006) and from eight other studies were
combined to investigate acute pulmonary inﬂammation for ﬁve different material types, a wide range of primary particles in
the nano-size range (diameter: 9–535 nm), mass-speciﬁc BET surface areas (6–800 m2/g) and dose range (several orders of
magnitude) (see Table 1). The ﬁve different types of biopersistent materials comprise polystyrene, two types of titanium
dioxide (TiO2), six types of carbonaceous materials (including ﬂame soot, diesel soot and carbon black (Printex90)) as well as
transition metal oxides (Co-, Ni-, and Zn-oxides) and hydrothermally synthesized α-quartz (α-crystalline silica, SiO2). A total
number of 53 data points were included in this study.
High quality of the allometric dose scaling approach used here is a prerequisite for combining rat and mouse data in this
retrospective-analysis. This issue was examined using the ﬁve TiO2 data sets for mice (1) and rats (4) obtained in different
laboratories (see Table 1). As seen from Fig. 1A there is excellent agreement between the dose–response curves from all ﬁve
data sets. The logarithmic ﬁt of PMN number versus BET surface area dose explains 91% of the variability of the toxicological
Fig. 1. Dependence of acute lung inﬂammation on BET surface area dose for various types of nanoparticles (NPs). Lung inﬂammation is expressed in terms
of the number of inﬂammatory cells (PMNs, normalized to total number of cells) recovered from the lung 16–24 h after intratracheal instillation of NPs into
the lung. (A) Allometric scaling of mouse and rat data provides consistent results unifying ﬁve different TiO2 data sets (R2¼0.91). Inter-species and inter-
laboratory differences in the dose–response curves are reasonably small as indicated by the tight clustering of all data about the ﬁt line. (B) Four different
types of low-solubility, low-toxicity (LSLT) materials show relatively tight clustering of the dose–response curves (dashed lines indicate the 71σ levels of
(solid) best ﬁt line). In spite of signiﬁcant differences in primary particle diameter and mass-speciﬁc BET surface area (see Table 1) there is good correlation
between inﬂammation and logarithmic BET surface area dose (R2¼0.76). The EC50 dose (dose inducing 50% of the maximum observed effect level (MOEL);
here: 30% PMN) is 175 cm2/g-lung (geometric mean; 85 and 405 cm2/g-lung corresponds to 71σ dose levels).
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PMN data from rats and mice on the same dose-scale. Moreover, Fig. 1A also shows great consistence of data from different
laboratories which is another prerequisite for reliable retrospective-analysis of data from different laboratories.
The dose–response data presented in Figs. 1 and 2 show a sigmoidal shape with a no observed effect level (NOEL)
between 0% and 5% (no inﬂammation) for low doses and an asymptotic maximum response level between 50% and 70%
(maximum (100%) observed effect level (MOEL)) for high doses. As both the asymptotic NOEL and MOEL are not far enough
explored for sigmoidal curve ﬁtting, we performed logarithmic dose–response ﬁts over the entire data set and compared
particle-speciﬁc toxicities based on EC50 values, i.e. effect concentration (or dose) at 50% of MOEL (¼30% PMN) as seen in
Fig. 1B. As the logarithmic ﬁt is not valid for PMN values below 5% and above 60%, the ﬁt curves are truncated at these PMN
values.
Fig. 1B depicts acute pulmonary inﬂammation induced by four different types of materials with similar toxicological
classiﬁcation, namely polystyrene, TiO2, (six types of) carbonaceous materials and hydrothermally synthesized nano-quartz
(Table 1). Again there is good linear correlation between (logarithmic) dose and toxicological response (R2¼0.76) for BET
surface area as the dose metric. The derived EC50 dose corresponds to a (geometric) mean surface dose of 175 cm2/g-lung.
Moreover, all data are clustering relatively tightly about the dose–response ﬁt curve resulting in EC50 dose variability from
85 to 405 cm2/g-lung (71σ dose limits). This dose range corresponds to a moderate geometric standard deviation of 2.2
(¼(405/85)0.5) about the geometric mean, which is similar to the width of typically observed aerosol size distributions such
as produced by standard aerosol generators. Consequently, the four types of materials presented in Fig. 1B can be cate-
gorized as a speciﬁc toxicity class sometimes referred to as low-solubility, low-toxicity (LSLT) materials without intrinsic
toxicity.
Fig. 2 compares the toxicity of transition metal oxides (cobalt (Co), nickel (Ni), zinc (Zn)) to that of LSLT materials. As seen
in Fig. 2A the EC50 dose for the investigated transition metal oxides is 15 cm2/g-lung indicating that cobalt, nickel and zinc
oxide show 12-fold higher BET surface-speciﬁc toxicity than LSLT particles (EC50¼175 cm2/g-lung). Virtually the same result
Fig. 2. Comparison of acute lung inﬂammation induced by low-solubility, low-toxicity (LSLT, see Fig. 1B) and transition metal oxide NPs (here cobalt, nickel
and zinc) with BET or geometric surface area as dose metric. For both BET surface area (A) and geometric surface area (B) as the dose metric, transition
metal oxides show a 12-fold elevated toxicity compared to the LSLT particles as evidenced by corresponding EC50 values of 175 cm2/g-lung (with 85 and
405 cm2/g-lung as 71σ limits) and 15 cm2/g-lung, respectively.
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transition metal data points could be converted into geometric volume due to a lack of particle-speciﬁc information (see
Table 1). In light of the wide range of primary particle diameters (9–535 nm), the absence of any signiﬁcant size-dependent
particle toxicity is remarkable and documents the biological relevance of surface area as dose metric.
In addition to surface area other dose metrics were investigated. Fig. 3 shows the same data as depicted in Fig. 2, but
presented in terms of mass, volume, number, and joint length. Using mass and volume as the dose metric shows a cor-
relation coefﬁcients of R2¼0.49 and 0.52, respectively (Fig. 3A and B), which is signiﬁcantly lower than the 0.76 (or 0.78) for
BET and geometric surface area, respectively (Fig. 2). Moreover, the higher toxicity of transition metals compared to LSLT
materials is not evident for mass and volume as the dose metric. Expressing the dose–response curves in terms of number
and joint length of the primary NPs (only LSLT particles were considered), yields even lower dose–response correlation
coefﬁcients of 0.19 and 0.41, respectively (see Fig. 3C and D). The relatively high correlation coefﬁcient of joint length
compared to number concentration in spite of very similar scatter plots is a result of the fact that the relative x-axis range is
much narrower for length than for number (ca. 3 and 5 orders of magnitude, respectively). However, both metrics display a
size-dependent stratiﬁcation of the data, with larger primary particle diameters inducing larger PMN inﬂux. However, this is
an artefact due to the larger surface area per particle for larger sizes. Hence neither number nor joint length is a suitable
dose metric for LSLT particles.4. Discussion
The retrospective-analysis presented here identiﬁes surface area as the biologically most relevant dose metric for non- or
low-solubility NPs of spherical shape. However, this analysis is based on non-physiologically applied NPs using intratracheal
Fig. 3. Acute lung inﬂammation data from Fig. 2 presented in terms of four different dose metrics. (A) and (B) Mass and volume (normalized to macrophage
volume) show a moderately good correlation with inﬂammation (R2¼0.49 and R2¼0.52, respectively), but – in contrast to surface area – there is no clear
distinction between the toxicity of LSLT and transition metal oxide NPs possible. (C) and (D) For number and joint length of the primary particles as the
dose metric, the correlation with inﬂammation reduces to R2¼0.19 and 0.41, respectively, (only LSLT data are considered). Moreover, the data suggest an
enhanced toxicity of larger particles (size-stratiﬁcation indicated by solid lines), which is a metric-related bias due to the increase in surface area per
particle for larger particles.
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ment. Hence, it is important to compare our ﬁndings to results from inhalation studies. Numerous chronic (414 weeks of
exposure), sub-chronic (1–14 weeks) and acute (o1 weeks) animal inhalation studies are also providing evidence for
surface area as the biologically most relevant dose metric for non-soluble particles. For instance, the lung tumor prevalence
occurring in animal models after chronic inhalation of toner, coal dust, talk, titanium dioxide, diesel soot and carbon black
particles was found to be well correlated with pulmonary surface area dose (Maynard & Kuempel, 2005). Another
retrospective-analysis of animal data on the carcinogenicity of inhaled particles found elevated toxicity of particles smaller
than 100 nm for mass as dose metric, but no size-dependence for surface area or volume dose (Gebel, 2012). Also short-term
inhalation studies with different sized silver NPs implied surface area as the biologically most relevant dose metric for acute
pulmonary inﬂammation (Braakhuis et al., 2015). The toxicological impact of surface area may be rationalized by the fact
that only molecules on the particle surface area are in direct contact with bodily ﬂuids and tissue. Hence, effects such as the
rate of dissolution of toxic components, formation of reactive oxygen species, or depletion of proteins/lipids in bodily ﬂuids
due to the formation of a protein or lipid corona and subsequent adverse effects on cell homeostasis are likely to depend on
particle surface area dose (Fubini, Ghiazza, & Fenoglio, 2010; Stoeger et al., 2009; Xia et al., 2006).
However, there are also inhalation studies championing volume as biologically most relevant dose metric. In a
retrospective-analysis of sub-chronic inhalation studies (4–13 weeks exposure) with a wide variety of particle types (e.g.
AlOOH, Fe2O3, TiO2, multi-walled carbon nanotubes – in entangled, agglomerated form), it was shown that PMN inﬂux in
the lung was best correlated with the volume burden of the particles in the lung (Pauluhn, 2009, 2011). The dose–response
curves were consistent with the well-known overload paradigm of particle toxicity, which claims that particles without
inherent toxicity are non-toxic in chronic inhalation scenarios unless the pulmonary particle volume burden exceeds 6% of
the macrophage volume of the lung (Pauluhn, 2011). Once this dose threshold, known as the overload condition, is reached
the mobility of alveolar macrophages and their ability of clearing particles from the alveolar surface is retarded leading to
chronic inﬂammation and associated adverse health effects (Pauluhn, 2011). A more in-depth discussion of lung particle
overload and its role for deriving occupational exposure levels for nanoparticles has been presented by an editorial and two
companion papers recently published in Particle Fibre Toxicology (Borm, Cassee, & Oberdorster, 2015; Morfeld et al., 2015;
Pauluhn, 2014).
In addition to surface area and volume, particle number has been identiﬁed as biologically effective dose metric for stiff,
biopersistent, ﬁber-like particles such as asbestos or other ﬁber-like particles. While short ﬁber-like particles can be easily
phagocytized, ﬁber-like particles longer than 5 mm (some say longer than 15–20 mm) are too long for macrophages to
completely engulf them. This frustrated phagocytosis results in persistent inﬂammatory stimulation leading to ﬁbrotic or
carcinogenic tissue degradation (Archer, 1979; Murphy, Schinwald, Poland, & Donaldson, 2012). As each ﬁber can eliminate
at least one macrophage, particle number is the biologically most effective dose metric for this mode of action.
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consuming and expensive for rigorous risk assessment. Hence, intratracheal instillation animal studies on acute lung
inﬂammation may serve as cost effective, reliable, early indicator of potential adverse health effects of inhaled particles.
Fig. 1A conﬁrms that both inter-species (mouse and rat) and inter-laboratory variability is sufﬁciently small to obtain
consistent data sets from rodent studies performed in different laboratories. In the present retrospective-analysis we
investigated the moments of the particle size distribution (0th, 1st, 2nd and 3rd moment correspond to the number-, length-,
surface-area-, volume-/mass-weighted particle size distribution, respectively) for their biological relevance for acute lung
inﬂammation in animal models.
Clearly, primary particle number and joint length proved to be inferior to particle mass and volume (Fig. 3). This
assessment is not only based on the poor correlation coefﬁcient of number and length, but also on the size-stratiﬁcation of
the data (larger particles appear more toxic), which is most pronounced for number and length as the dose metric, but also
present in the volume and mass data (not shown in Fig. 3A and B), although to a much smaller degree. Historically, most of
the particle toxicity studies were performed with mass as the dose metric. While mass is an adequate dose metric for
soluble materials, it is inadequate for non- and low-solubility particles used here. In fact using mass as dose metric has led to
the false conclusion that smaller particles are inherently more toxic than larger ones (Gebel, 2012). On the other hand,
smaller particles appear to be less toxic than larger ones, if number or length is chosen as the dose metric. This apparent
dependence of toxicity on particle size vanishes, if surface area is used as the dose metric as shown by our and numerous
other studies (Braakhuis et al., 2015).
Volume dose displayed similarly mediocre correlation with acute inﬂammation as mass. For none of the cases investi-
gated here, the overload dose (6% of macrophage volume) was exceeded (Fig. 3B). Hence, the observed signiﬁcant acute
inﬂammatory response for some cases cannot be explained with the overload paradigm. In fact the overload paradigm refers
to chronic inﬂammation where long term retention of the alveolar deposited particles and subsequent epithelial irritation is
of signiﬁcance and not to acute effects. Hence, this mode of action is not expected to be relevant for the data analyzed here.
The retrospective-analysis of acute lung inﬂammation data indicates that surface area is the biologically most effective
dose metric with no signiﬁcant difference between BET or geometric surface area (Fig. 2B), which is consistent with the fact
that the materials investigated here had smooth surfaces without signiﬁcant microporous structures. This can be seen from
the ratios of geometric and BET surface area ranging from 0.41 to 1.5 with most of the particles clustering about unity
(Table 1). For microporous and non-spherical particle shapes (except ﬁbers) BET rather than geometric surface area is
expected to be the biologically more effective (or more easily determined) dose metric. In contrast to geometric surface area,
there is currently no real-time measurement method for BET surface area. Thus, the fact that for spherical particles with
smooth surfaces the geometric surface area can be used as biologically most relevant dose metric has severe practical
implications for exposure measurements. Using recently described multi-instrument approaches it is possible to determine
all moments (0th–3rd moment) of nanoparticle size distributions for both spherical and agglomerated (smooth) spherical
NPs as required for nanoparticle inhalation risk assessment (Shin et al., 2010; Wang et al., 2010).
The close proximity of the dose–response curves of the four different types of LSLT materials (polystyrene, TiO2, car-
bonaceous materials, smooth quartz) depicted in Fig. 2 indicates that these materials have similar surface-speciﬁc toxicity
possibly due to similar catalytic activity of the surface. These types of materials are considered materials without intrinsic
toxicity. On the other hand, it is well known that certain transition metal oxides and milled quartz have enhanced toxicity.
Fig. 2 shows evidence for 12-fold enhanced surface-speciﬁc toxicity of Co-, Ni- and Zn-oxide compared to LSLT materials.
This can be attributed to the production of highly toxic free OH-radicals from hydrogen peroxide (Fenton reaction) and
uptake of particles in intracellular compartments (the endo-lysosomal system) with low pH, where partial dissolution leads
to enhanced release of high (toxic) concentrations of metal ions in the cells. This so-called Trojan horse effect can also lead
to an imbalance of the intracellular homeostasis of otherwise tightly regulated metal ions and subsequent inﬂammatory
response. These additional modes of action account for the enhanced surface-speciﬁc toxicity of transition metal compared
to LSLT NPs. Our study also shows that synthesized, nano-sized α-crystalline silica (α-quartz) belongs to the LSLT toxicity
class (Fig. 2). This may seem surprising as numerous studies report elevated surface-speciﬁc toxicity for quartz particles such
as Min-U-Sil (Warheit, Webb, Colvin, Reed, & Sayes, 2007), which was not included here because of its irregular particle
shape and its primary particle size outside the nano-scale range (typically much larger than 1 mm diameter). For grinded
crystalline quartz (like Min-U-Sil), it has been hypothesized that the sharp-edged particles can cause lysosomal membrane
destabilization, which contributes to the elevated inﬂammatory toxicity (Sun, Wang, Ji, Li, & Xia, 2013). In contrast, the
hydrothermally synthesized nano-quartz included here does not activate lysosomal destabilization due to its smooth surface
structure (Warheit et al., 2007). In absence of this toxicity mechanism, nano-quartz shows the same toxicity level as all the
other LSLT particles.
The analysis presented here also indicates that primary particle size has no effect on surface-speciﬁc particle toxicity. As
caveat we add that this study was not designed to study effects of primary particle size on surface-speciﬁc toxicity. Hence,
we cannot rule out that size-dependent effects do occur especially for very small primary particle sizes, where quantum
effects may come into play. Moreover, many toxicologically relevant modes of action such as endocytic cellular uptake of
non-professional phagocytic cells depend on agglomerate rather than primary particle size. The means of application
(intratracheal instillation) suggests that rather large agglomerates had formed either in the particle suspension or on the
lung epithelium. Thus, we can only conclude that for agglomerated LSLT particles the combined effect of primary particle
size and material type on acute lung toxicity is less than a factor of 4.8 (2σg of EC50; see Fig. 1B).
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effective, lung-deposited surface area concentration is expected to be the biologically most effective dose metric for non-
soluble NPs. This is evident from Eq. (4), describing the relationship between the effective lung-deposited surface area dose
(DoseSAeff) and the surface area (or mass) exposure level of the aerosolized nanoparticles
DoseSA;ef f ¼ f tox _V t
Z
mðDÞsaðDÞDepðDÞ½ dD; ð4Þ
where m(D)¼dM/dD is the differential particle mass distribution (D¼particle diameter, M¼aerosol mass per volume air),
Dep(D) is the size-dependent fraction of inhaled particles deposited onto the lung epithelium (see e.g. ICRP, 1994; Londahl et
al., 2014), sa is the mass-speciﬁc surface area of the particles, t is the exposure time and _V is the ventilation rate of the lung
(inhaled air volume per time). To account for different relative toxicities (high and low toxicity class) the toxicological
weighting factor ftox is introduced which accounts for differences in surface-speciﬁc toxicity, which can be deﬁned as the
inverse of the normalized surface-based EC50 value, where the LSLT EC50 value is a suitable normalization constant (i.e.
ftox¼12 and 1 for transition metal oxide and LSLT nanoparticles having EC50 values of 15 and 175 cm2/g-lung, respectively). If
any of the parameters in Eq. (4) is time-dependent, time averages have to be used or the right hand side of Eq. (4) has to be
integrated over time as well. For long-term exposures, time-dependent particle clearance rates (from the lung) may have to
be included as well (ICRP, 1994).
The integral term in Eq. (4) represents the lung-deposited surface area concentration, which – under certain conditions –
can be measured in real-time by electrometer-based measurement techniques (e.g. NSAM or AeroTrak by TSI, Partector by
Naneos; (Fissan et al., 2007)). These devices provide reliable lung-deposited surface area concentrations for smooth,
compact particles with diameters between about 20 and 300 nm, i.e. they do not necessarily adequately account for effects
of shape, agglomeration state or surface-porosity on surface area (Wang et al., 2010). These instruments do also not account
for hygroscopic particle growth in the lung making the results unreliable for (partially) water-soluble particles. Thus, for
non-soluble compact particles only are electrometer-based measurement techniques expected to provide a valuable tool for
real-time exposure measurement of the biologically most effective particle dose (lung-deposited surface area dose).
Moreover, for agglomerated spherical NPs, multi-instrument approaches can be used for real-time measurement of both
primary particle size and particle number which can then be converted into derived surface area (for smooth surfaces) and
volume concentration (Shin et al., 2010; Wang et al., 2010) and ultimately into lung-deposited dose by accounting for the
known size-dependent lung deposition fraction (ICRP, 1994; Londahl et al., 2014).
As seen in Fig. 2 spherical nanoparticles can be stratiﬁed into surface-based classes of toxicity. As suggested in Eq. (4)
these differences in surface-speciﬁc toxicity can be incorporated into risk assessment by deﬁning appropriate toxicity
weighting factors. For instance our retrospective-analysis suggests that transition metal oxides and LSLT particles can be
presented by ftox¼12 and 1, respectively, based on the ratios of the corresponding EC50 values. Recently, there have been
attempts of deﬁning equivalent toxicological doses using the concept of lung-deposited surface area and appropriate
weighting factors accounting for enhanced health risks due to e.g. highly toxic materials, surface roughness and the
occurrence of frustrated phagocytosis (Simko, Nosske, & Kreyling, 2014).
As discussed above the EC50 doses presented here are expected to provide a valuable tool for comparing the relative
toxicity of different types of nanoparticles, but they are not suitable as sole basis for recommended exposure limits of
nanoparticles (absolute toxicity). The latter is mainly because exposure limits should be based on chronic inhalation studies
rather than on acute instillation studies as presented here. Nevertheless, from the perspective of exposure assessment it is
instructive to relate the EC50 values derived here to corresponding exposure concentrations. Assuming a worst case
exposure scenario, the EC50 values of 175 and 15 m2/g-lung for nanoparticles belonging to the low and high toxicity class
deﬁned in Fig. 2, respectively, are allometrically equivalent to the lung-deposited surface area dose received by a person
during an 8-h work shift at an aerosol mass concentration of 360 and 30 mg/m3, respectively. Here, the following worst case
assumptions were made: The worker conducted heavy work during the entire 8 h shift (3 m3/h ventilation rate, (ICRP, 1994),
the lung deposited aerosol fraction in the alveoli is 60% (ICRP, 1994) and the mass-speciﬁc surface area of the nanoparticles
is 1000 m2/g. Allometric scaling of the lung deposited particle dose from mouse/rat to man was based on an assumed lung
surface area of 100 m2 and 600 cm2 (for a 0.18 g mouse lung) for man and mouse, respectively (Kida et al., 1989; Paur et al.,
2011; Stone, Mercer, Gehr, Stockstill, & Crapo, 1992). Thus, the rodent-derived EC50 doses of 175 and 15 m2/g-lung can be
converted into corresponding human EC50 doses of 530 and 45 cm2/m2-lung (surface area NP per surface area of lung
epithelium), respectively. We reiterate that these exposure levels should not be interpreted as guidance for NP workplace
exposure limits, because of the difﬁculties of relating acute pulmonary effects observed after instillation of NP into the lung
to adverse health effects due to chronic inhalation scenarios.5. Conclusions
The retrospective-analysis provided here showed that allometrically scaled animal data from mice and rats provide
species- and laboratory-independent information on the pulmonary toxicity of intratracheally instilled nanoparticles (NPs).
For low- and poorly-soluble spherical NPs, (lung-deposited) particle surface area emerged as the biologically most effective
O. Schmid, T. Stoeger / Journal of Aerosol Science 99 (2016) 133–143142dose metric for acute pulmonary inﬂammation. As expected, there was no signiﬁcant difference between BET and geometric
surface area as dose metric for NPs with relatively smooth surface structure (no micro-pores).
Using surface area as the dose metric, allowed identiﬁcation of material-based toxicity classes independent of particle
size. Materials with no intrinsic toxicity like polystyrene, carbonaceous materials, titanium dioxide and synthesized
(smooth) α-quartz (but not for grinded sharp-edged quartz) showed similar dose response curves with EC50 values (half-
maximum response level: here 30% PMN inﬂux into the lungs) clustering in a narrow dose range between 85 and 405 m2/g-
lung (geometric mean at 175 m2/g-lung; geometric standard deviation of 2.2). This toxicity class was referred to as low
solubility, low toxicity (LSLT) class. It is noteworthy that not only (aged) diesel soot, but also all other ﬁve types of carbo-
naceous materials considered here belong to the LSLT class suggesting that also ambient urban ultraﬁne particles might
belong to the LSLT class at least in the absence of highly toxic material adsorbed onto the core of these particles. For
transition metal oxides (here: Co, Ni, Zn), which are considered materials with intrinsic toxicity, a surface-speciﬁc toxicity
enhancement factor of about 12 compared to LSLTS particles was found (EC50¼15 m2/g-lung).
As caveat we add that applying NP suspensions rather than freshly generated aerosols may have an effect on the
observed surface-speciﬁc toxicity due to interactions of the dispersion medium with the particles. However, the notion that
surface area is the most relevant dose metric for particle toxicity has also been shown by numerous inhalation studies.
Depending on the mode of action, dose metrics other than surface area may be more effective. For instance, volume and
number are biologically more effective dose metrics for high particle lung burden (overload conditions; more than 6% of
alveolar macrophage volume is ﬁlled with particles) and long, stiff ﬁber-like particles (frustrated phagocytosis). In addition,
mass should be included as dose metric due to its historic and regulatory relevance for NP toxicity.
With these limitations in mind lung-deposited particle surface area dose can be expected to be the toxicologically most
relevant dose metric for inhaled, spherical NPs. Hence, future aerosol exposure measurements related to health effects of
inhaled particles should strive to include lung-deposited particle surface area concentration as main exposure parameter.Acknowledgments
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